Brain, Aging, Synapses
Introduction
Aging leads to a progressive decline in brain and body function. It is characterized by heterogeneity, because some individuals may show less deficits and/or possess better adaptive mechanisms that compensate for losses and preserve key-functions.
A probable definition of aging could be: "an irreversible process that begins at m aturity and is characterized by increasing deviations as com pared to the ideal functional state" (Siegel et al., 1989) .
With aging, both "norm al" senescent age-re lated changes (ARCs) and late-onset diseases af fect the brain, produce declines in performance. The brain, as a postmitotic structure, is particularly vulnerable to ARCS and senescence is by far the most powerful risk factor for neurological diseases of the elderly such as sporadic Alzheim er's dis ease. Both individual and species differences in longevity illustrate the variable effects of time. Hum an life expectancy has been extended by pre vention and treatm ent of specific diseases and life span can be altered by modifying the processes producing ARCs (Drachman, 1997) .
The advent and im plementation of new designbased stereological techniques allow the quantifi cation of cell num ber without the assumptions re quired when obtaining areal densities. This newly emerging view of retained cell num ber during aging has a major impact on biogerontology, prompting re-evaluation of the long-standing hy pothesis of age-related cell loss as a cause of agerelated functional impairments in brain (Long et al., 2000) .
Aging is determined by the following features: a) It is the last period of one's life, b) it is m et in every kind of species, c) it is not defined by the environment, d) it is evolutionary and e) it causes degenerative lesions and dysfunctions of CNS (Leclercq, 1992) .
Synaptic number and structure
Neuronal loss seems to exist in aging animals, confined to specific brain areas whereas synaptic junctional areas are remodelled through lifespan. In the elderly, the num ber of contacts and the total surface area of the synapses decrease significantly and their average synaptic size increases at a dif-ferent extent according to the brain area taken into account. This is probably due to a compensa tory phenom enon, counteracting the synaptic re duction in num ber (Bertoni-Freddari et al., 1996) .
Synaptic structure shows a variety of develop m ental changes. Pre-and postsynaptic elements thicken with age, while vesicle size decreases. A d ditionally, a small increase in synaptic element length is observed early in the development but no change in cleft width or in the num ber of synaptic vesicles (M arkus et al., 1987) .The role of synaptic vesicles in neuronal developm ent and plasticity is of great interest, since alterations in synaptic vesi cles have been associated with a num ber of func tional states (Pysh and Wiley, 1972; Vrensen and D eG root, 1974; Gully, 1978; Reinecke and Wal ther, 1981; De Voogt et al., 1985; Riccio and M at thews, 1985; Markus, 1987) .
Although synaptic transmission is an important means of com m unication between neurons, neu rons themselves and neurons and glia also commu nicate by extrasynaptic "volum e" transmission, which is m ediated by diffusion in the extracellular space (ECS). The ECS of the central nervous sys tem (CNS) is the microenvironment of neurons and glial cells. The composition and size of ECS change dynamically during neuronal activity as well as during pathological states. Following their release, a num ber of neuroactive substances, in cluding ions, mediators, metabolites and neuro transm itters diffuse via the ECS to targets located a long distance apart from their release sites (Sykova and Chvatal, 2000) .
Synaptic vesicle size and num ber depend on the status of the nerve term inal, prior to and during fixation, varying with the nature of the fixative and the fixative-induced release, where the observed changes in vesicles are due to development (M ar kus et al., 1987) .
Neurochemical changes
The aged brain presents a failure in almost every transmission system and at almost every step of the chemical transmission process (Agnati et al., 1990) . It may be suggested that a general decrease of transm itter content, receptor density and trans duction mechanism efficacy can cause a reduction of the set-point of synaptic feedback mechanisms , and more generally, a de- creased functional reserve of synaptic transmission (Table I) . Moreover, chemical signals should be secreted in relatively high amounts to reach dis tant high-affinity receptors at sufficient concentra tions. Furtherm ore, changes of the proteolytic enzyme concentrations in the neuronal membranes facing the extracellular fluid, or in the chemical composi tion of the extracellular matrix, may play a role in aging (Agnati et al., 1990) . The observed increase of the brain protease activity during aging may also include alterations in the enzyme substrate specificity and/or in its endogenous substrates (susceptibility to breakdown) (Benuck et al., 1996) .
The failure in integrating neuronal and hor monal signals has also been reported during aging (Angelucci et al., 1983) . It has been proved that the proper spatio-tem poral convergence of neuro transmitters, neuropeptides and peripheral hor mones onto neuronal networks, undergoes an agerelated alteration, which probably explains the im pairment of some intellectual performances in aged subjects.
Additionally, adenosine receptors show age-related changes. A statistically significant decrease is observed in the density of A l and A2 adenosine receptors in the aged rats (24 months old), as adenosine inhibits the release of several neuro transmitters, such as acetylcholine (ACh), dopa mine (DA), noradrenaline (NA), serotonin (5-HT), glutamate and gamma-aminobutyric acid (GABA) (Fredholm and Dunwiddie, 1988 ). An overall reduction of this inhibitory mechanism could, in part, explain the well known "release" phenom ena, such as involuntary movements, sud den unrelated emotions and, more generally, psy chological instability, often observed with the elderly.
M oreover, it has been suggested that adenosine may have protective effects (Dragunow and Faull, 1988) , possibly regulating blood flow (mainly via A 2 vascular receptors) and reducing oxygen ( 0 2) demand (mainly via A x central receptors). These responses are triggered when a m arked reduction in energy storage is required and a pronounced ATP hydrolysis, following an increase in the central nervous system (CNS) metabolic demands (e.g. after ischemia, hypoxia, etc). Thus, adenosine may play a crucial role in balancing energy ex penses with energy storage in the brain. A reduc tion in this control system may lead to sudden fail ures of the "basic biochemical machinery", which is the basis of any plastic response. Increasing evi dence (Agnati et al., 1988) indicates that an im por tant step to ensure neuronal survival, after m e chanical and toxic lesions, may be the reduction of neural electrical activity which accounts for about 60% of the entire neuronal energy expenditure.
A previous study reports that the intracytoplasmic part of chemical trans mission is less effective during aging. In fact, both cAMP and calcium-induced protein phosphoryla tion appear to be reduced in the striatal and corti cal regions. A n impaired phosphorylating activity could also contribute to alterations in the response of receptors to neurotransm itters in the aging brain. In this view, the m odulation of protein phos phorylation may restore some functional changes of the aging brain, from short term events (e.g. ion channel activity), to long-lasting processes, (e.g. the potentiation of synaptic efficacy). In addition, it is believed that drug administration, as well as the exposition to harmful substances, may in terfere with neurotransm ission mechanisms. For example, excessive alcohol consum ption has been shown to alter biochemical and homeostatic events, from receptor adaptive phenom ena to transducing systems (Magnoni et al., 1990) .
A t membrane level, there is a change in the in teraction with chemical transmissions (Agnati et al., 1984; Agnati, 1985 and . This phenom enon can be explained as a reduction in the miniaturization of the computing circuits of the brain at molecular level, resulting not only in an impaired transmission of information, but also in a decrease in the m em brane capability to integ rate the chemical signals . These membrane phenom ena suggest that the m orphofunctional changes observed in the aged brain can explain, at least in part, the decreased capability of the aging nervous system to store and retrieve information.
The most im portant functional consequence of the above alterations is the inability of the "aged" synapse to give prom pt and effective responses, to allow interactions between different chemical transmissions and thus, to be a part of an effective optimal control system.
Neurotransmitters and the aging brain
Aging affects mostly the cholinergic and catecholaminergic system (Xafenias and Hampatzis, 1995) . a) Catecholaminergic system: i) DA-neurons in the substantia nigra of the hum an brain are selec tively vulnerable and their num ber declines about 5 -1 0 % per decade of aging (Naoi and M aruyama, 2000) . As a result, there is a decline in DA func tion (Volkow et al., 1998) , which is also related to the decreased activity of the enzymes tyrosine hydroxylase and L-dopa decarboxylase. In addi tion, aging of the human brain is associated with a decline in dopamine (DA) function, generally in terpreted as DA cell loss. Positron emission to mography studies revealed that in healthy individ uals, the age-related losses in DA transporters (presynaptic m arker) were associated with losses in D2 receptors (postynaptic m arker) rather than with increases as is known to occur with DA cell loss. This association was specific for DA synaptic markers, because they were not correlated with striatal metabolism. Furtherm ore, their association was independent of age, suggesting that a common mechanism regulates the expression of receptors and transporters irrespective of age (Volkow et al., 1998) .
ii) NA appears to be reduced, mainly in the hindbrain, because of the reduction of its receptor density (Xafenias and Hampatzis, 1995) .
iii) Distributional changes of serotonergic fibers associated with aging were dem onstrated immunohistochemically. Old rat brains were morphologi cally characterized by the presence of peculiar fea tures of serotonergic fibers not found in the young adult brain. In 24-month-old rats, these aberrant serotonergic fibers were subdivided into two groups according to morphological alterations: type 1 fibers consisting of thin fibers with m oder ately enlarged varicosities and type 2 fibers con sisting of much thicker fibers that have even larger varicosities and a tortuous course. These two types of fibers were distributed differentially in the fore brain. Type 1 fibers were found mainly in the stria tum and frontoparietal cortex, whereas type 2 fi bers were found in the posterior cingulate cortex and dentate gyrus of the hippocampal formation. Both types of aberrant fibers were seen in amyg dala, frontoparietal cortex, hypothalamus and thalamus. In 36-month-old rats, more highly de generating arborizations were detected, and these aberrant ramifications were classified as follows based on shape as: type 3 fibers consisting of highly arborized thin fibers with a larger number or larger varicosities, and type 4 fibers consisting of thick fibers with abundant larger varicosities. Distributional difference indicated that type 1 fi bers develop into type 3 fibers, and type 2 into type 4 fibers. These findings suggest the possibility that one set of pathological fibers em anate from the dorsal raphe nucleus and the other from the median raphe. M oreover, both two sets of seroton ergic fibers show age-related aberrations in their morphology over same time course (Nishimura et al., 1999) . iv) Monoaminoxidase (M AO) activity is re ported to increase remarkably. As a consequence of this finding, the acetylenic selective monoamine oxidase (M AO) type B suicide inhibitor selegiline ([R]- [-] -N, a-Dimethyl-N-[2-propynyl] phenethylamine) (previously called L-deprenyl) has proved to be useful adjuvant to levodopa (L-Dopa) ther apy and m onotherapy of Parkinson's disease (PD). The drug binds to brain regions with a high MAO-B content, such as the thalamus, the striatum, the cortex and the brainstem. It is rapidly metabolized in humans, mainly in the liver, to form desmethylselegiline and m etham phetam ine, which are fur ther metabolized to am phetam ine (phenylisopropylamine). Although not all features of its anti-PD action area known, brain studies have shown that selective inhibition of MAO-B, with the concomi tant increase of phenylethylam ine and dopamine (DA) but not of serotonin or noradrenaline, in the basal ganglia may be regarded as its mode of action. These protective effects afforded by selegiline in PD, resulting in a delayed need for levodopa ther apy, have been variously interpreted in terms of the involvement of an endogenous neurotoxin or an oxygen free radical mechanism (oxidative stress) in the developm ent of PD (Gerlach et al., 1996) . b) Cholinergic system: Muscarinic receptor den sity is decreased with aging (Buyukuysal et al., 1998) . Choline acetyltransferase (ChAT), an en zyme implicated in the biosynthesis of ACh, shows a decreased activity. M oreover, acetylcholinester ase (AChE), has a decreased activity (Xafenias and Hampatzis, 1995) . Age-related alterations of presynaptic functions were studied in terms of ace tylcholine (ACh) synthesis and release using synaptosomes isolated from mouse brain cortices. The following three findings were obtained: 1) Choline acetyltransferase activity and ACh production rate remained constant throughout all ages tested. This observation, obtained with synaptosomes, was not consistent with data reported for brain slices. Vari ous conditions, such as low glucose or membrane depolarization, m odulated ACh synthesis to sim ilar extents in young and aged synaptosomes. 2) Depolarization-induced release of ACh from syn aptosomes significantly decreased in the senescent stage. The fraction of ACh released from aged syn aptosomes was less than that released from young synaptosomes, although the ACh contents in the synaptosomes did not change with age (Tanaka et a l, 1996) . c) GABA: This neurotransm itter is the "execu to r" of virtually all age-related neurodegenerative processes. With advancing age, the declining m ito chondrial ATP synthesis unleashes GABA synthe sis, leading to dystrophy of axon terminals and blocking the transport of the neurotrophins. As a result, "starvation" and death of neuronal somata are often observed (Marczynski, 1998) . d) Neuropeptides: Little is known about their participation in the aging process. With advancing age (in healthy individuals), neuropeptide Y (NPY) and corticotropin-releasing factor (CRF), seem to be decreased in gyrus cinguli (A rranz et al., 1996) .
In general, decreased transm itter release may be inconsequential during basal activity, but may be inadequate during periods of peak activity. Since neurotransm itter systems act in concert, it is pos sible that deficits in one transm itter may be com pensated for by changes in another, but a decline in two interdependent transm itter systems may produce more than an additive decline. C urrent data suggest that age-related alterations need to be examined regionally, as well as according to cell type and transm itter system (Marczynski, 1998) .
The role of calcium ion homeostasis in brain aging
The regulation of Ca2+ influx and its compartm entalization is essential to presynaptic, as well as postsynaptic events. Calcium influx induced by depolarization was lower in the synaptosomal preparations from aged mice than in those from young mice. A strong positive correlation was ob served between the amounts of ACh released and increased calcium levels when the data for all preparations, both from young and aged mice, were plotted. This indicates that diminished calcium influx may cause the reduced ACh release by aged synapses (Tanaka et al., 1996) .
Additionally, calcium ion homeostasis in dif ferent brain com partm ents (e.g. pre-and postsyn aptic) may respond to aging in a different way. Cy tosolic free Ca2+, which is the active pool of Ca2+, is only 1/10,000th of total neuronal Ca2+. Thus, changes in the intracellular/extracellular Ca2+ ra tio could produce harmful alterations in cell func tion. Consequently, the increase of calcium levels in the cytosol is the common factor of all the neurodegenerative processes affecting the nervous system (Ram irez-Exposito and M artinez-M artos, 1998). A num ber of com ponents are also influ enced by Ca2+ homeostasis, including receptor m o bility, Ca2+ transport systems, Ca2+ binding pro teins and Ca2+-activated proteases.
Furtherm ore, in the hippocampal slice prepara tions found that synaptic plasticity was impaired with aging, apparently due to excess Ca influx. In subsequent analyses it was found that the Ca-dependent afterhyperpolarization, the Ca action po tential and voltage-activated Ca currents were all K. Schulpis et al.
• Aging vs Brain Synapses increased in aged CA1 neurons. This was not due to impaired inactivation processes. Multiple types of Ca channels appear to be affected by aging. A long Ca tail current was also found in these studies, which seems to represent an unrecognized and significant Ca entry pathway at resting poten tial. In primary cell cultures, Ca currents and single Ca channels increase steadily over the life cycle of the cultured neurons and are correlated with cell death. Single L-type Ca channels were also studied in brain neurons of an aged mammal (rat), using the partially dissociated ("zipper") hippocampal slice preparation. A substantial increase in the density of functionally available Ca channels was present in CA1 neurons of aged rats, similar to the increase seen in cultured neurons. Thus, a gradual increase in the density of Ca channels appears to be a consistent property of hippocampal neuronal aging and might well be a factor in the vulnerabil ity of aged neurons to Alzheim er's disease and other neurodegenerative/traum atic conditions (Landfield, 1996) .
Synaptic plasticity during aging
Structural plasticity accompanying the aging process is not yet well understood. It is note worthy, however, that the elimination of the syn apses is highly selective during aging (Barnes, 1988; Flood and Coleman, 1988) . According to re cent data, there is a dramatic decline in the levels of synaptic proteins involved in the plasticity of axons and dendrites (H atanpaa et al., 1999) . As far as neuronal dendrites are concerned, it has been observed that there is a decrease of the dendritic branches and their endings, their total dendritic length and their cell soma size during aging pro cess (Anderson and Rutledge, 1996) . The impaired synaptic plasticity in the elderly may contribute to cognitive dysfunctions. Thus, reactive synaptogenesis appears to be very im portant to the aging brain, where numerous neuronal losses and degen erative processes take place. A n other study showed that enriched rearing conditions restored the age-related decrease or synaptophysin contents. This might be due to increased numerical synaptic density or enhanced packing density of synaptic vesicles in synapses. The results of this study support the latter explanation; that is, synap tic vesicle contents were increased without changes in synaptic density. Synaptic plasticity in duced by environm ental stimulation is shown to relate with synaptic strengthening, but not with the formation of new synapses (Nakamura et al., 1999).
In aged animals, the innervation process is de layed. The decreased rate of synaptic replacement may be due to the rate at which degenerative de bris is cleared from the neuropil. In aged rats, a delay in the initiation of clearance of degenerative debris was also observed, as a consequence of a slower innervation response (Siegel, 1989) .
M oroever, microglia also seems to play an im portant role in the clearance of degenerative de bris from the brain (Vijayan and Cotman, 1987) . In normal aging, reactive gliosis has been de scribed in specific areas of the limbic system and neocortex that undergo selective neuronal or syn aptic degeneration in nondem ented elderly per sons (Unger, 1999) .
New aspects of brain aging a)
F ree ra d ic a ls a n d a p o p to s is: Recent data in cell cultures has shown that brain neurons are par ticularly vulnerable to degeneration by apoptosis (programmed cell death). The main inducers of this phenom enon are oxidative damage and low energy metabolism (Cotm an and Su, 1996) . In fact, free radicals derived from oxygen may attack nerve terminals and peroxidize the membrane. W hen aged neuronal membranes are subjected to hyperoxia, their permeability to sucrose increases, while the synaptic plasma m em brane fluidity is de creased. The cholesterol/phospholipids (C/P) ratio of the membranes significantly increases with age, and even more in the oxygen-exposed rats. These results suggest that free radicals lead to the deteri oration of function of brain synapse, and that susceptibility of synapse to oxidative stress is re m arkably increased with age (U rano et al., 1998).
In a very recent study (Tsakiris, 2001a) , it was shown that the inhibitory effect of L-phenylalanine on rat brain AChE and its stimulatory effect on rat brain N a+,K+-ATPase were decreased with age, as a consequence of aging factors, such as free rad icals (Tsakiris et a l., 2000) and/or reduced density of a-and /^-adrenergic receptors in the tissue (Tsakiris, 2001b) .
Furtherm ore, the activities of antioxidant en zymes display an age-dependent decline in the old 926 rats, contributing to the serious oxidative protein damage seen in the elderly. For example, catalase and cytochrome C oxidase activities appear to be decreased during aging (Tian et a l., 1999) .
On the other hand, previous reports have indi cated that cholesterol (C H O ) accumulates in neu ronal m em branes and alters their structural and signal transduction properties during aging. Such an accumulation may serve to protect neuronal tis sue from oxidative damage. Actually, CHO seems to retard or enhance the harmful effects of oxida tive stress in an age-dependent m anner (Joseph e t al., 1997).
A nother neuroprotective factor against oxida tive damage, is N-acetylcysteine (NAC). It has re cently been found to prevent apoptotic death in neuronal cells and protect synaptic m itochondria proteins from oxidative stress in aged mice. Thus, the adm inistration of NAC may be beneficial for elderly subjects (M artinez e t a l., 2000). b)
T he ro le o f n itric o x id e ( N O ) in b ra in agin g:
NO is considered to have a cytotoxic action on neurons (Nom ura, 1996) . According to the "NO hypothesis of aging" (McCann e t a l., 1999), NO produces oxidant damage to the aging brain, and the effects of NO-synthase are m ediated mainly by the free radical oxidant properties of this solu ble gas. Antioxidants, such as m elatonin, vitamin C and vitamin E (a-tocopherol), probably play an im portant acute and chronic role in reducing or eliminating the harmful effects of NO. F urther more, there is evidence that nitric oxide (NO) plays an im portant role as a diffusible messenger in learning and memory, and was also examined the role played by NO in the effect of aging on spatial memory in rats. The perform ance of aged rats (30 months old) in a radial-arm maze task (a complicated action) was significantly impaired as compared to that of adult rats (3 months old). The num ber of neurons containing NADPH-diaphorase (NA DPH-d) reactivity in the cerebral cortex and striatum of aged rats was significantly less than that in the adult rats. The daily adm inistra tion of NG-nitro-L-arginine methyl ester (L-NAME; 10-60 mg/kg, i.p.) resulted in a dose-dependent im pairm ent of acquisition in the radialarm maze task, while it failed to affect previously acquired perform ance, i.e., retention, in the adult rats. The content of 5-hydroxyindoleacetic acid in the hippocampus and of 3,4-dihydroxyphenyla-cetic acid in the Striatum was significantly de creased and increased, respectively, in the L-NAM E (60 mg/kg/day)-treated adult rats com pared with that in controls. These findings dem on strated that NO production in the brain may be decreased in aged rats, suggesting that this alter ation may be involved in memory processes, espe cially in the acquisition, but not in the retention, of spatial learning in rats, and further, that endog enous NO may be involved in the regulation of dopam ine and 5-hydroxytryptamine metabolism (Noda et al., 1997) . c) Cerebral vessels and normal aging: The integ rity of the cerebral vasculature is crucial to the m aintenance of cognitive functions during aging. Prevailing evidence suggests that cerebrovascular functions decline with age. A num ber of subtle al terations in the intracranial vessels and capillaries are apparent. Thus, the neuronal populations in certain brain regions could become vulnerable, be cause of the hypoperfusion (Kalaria, 1996) . The aging of the cerebral microcirculation also affects the blood-brain barrier (BBB), which becomes m ore susceptible to disruption by external factors and drugs. However, it is not yet known w hether changes in the BBB contribute to the degenera tion of the aged brain or are merely epiphenom ena of aging (Shah and M ooradian, 1997) .
d) Metabolic features o f the aging brain:
The ex isting literature on chronic food restriction in ro dents shows the delay of some processes of aging in the nervous system and generally supports in teractions of peripheral metabolism with brain aging (Finch and Cohen, 1997) . Caloric restriction has been the most popular m ethod of extending life span in the laboratory animal. It causes a re duction of brain 5HT-levels, prevents age-related losses in striatal DA-receptors, and improves the learning performance in aged rats (Siegel, 1989) . Moreover, according to a recent study, adenosine s'-triphosphatase (ATPase) activity in the brain cytosol of 50-week-old rats was significantly de creased, as compared to that of 5-week-old rats (Hanahisa and Yamaguchi, 1999) .
e
) The possible neuroprotective role o f Insulin like Growth Factor-1 (IGF-I) and ovarian steroids:
IGF-I is a protein that acts on many tissues; it con tributes to the m aintenance of the integrity and homeostasis of the nervous system. The wide spread distribution of its receptor, allows IGF-I to affect the survival of numerous populations of neuronal and glial cells during aging and it seems that IG F-I can reduce or slow down neuronal losses (Drachm an, 1997) .
On the other hand, ovarian steroids affect brain areas such as the basal forebrain, hippocampus, midbrain raphe and brainstem locus coeruleus. Estrogens and progestins regulate synaptogenesis in the C A : region of the hippocampus. Formation of new exitatory synapses is induced by estradiol and involves N-methyl-D-aspartate (NMDA) re ceptors, whereas synaptic down-regulation in volves intracellular progestin receptors. F urther more, ovarian steroids affect the brainstem and m idbrain catecholaminergic neurons, midbrain 5-HT pathways and the basal forebrain cholinergic system, producing cognitive effects during aging (M cEwen et al., 1997) . Additionally, the neuropro tective efficacy of estrogens has been well de scribed. It has been reported that the estrogens activate the kinase pathway, regulate the cAMP signal transduction pathways, m odulate intracellu lar calcium homeostasis and show direct antioxi dant activity (G reen and Simpkins, 2000) . f) Stress and aging: A loss of endocrine and neurotransm itter system intractions may underlie the age-related deficits in the hypothalamic-pitu itary-adrenal axis, including adapting to stress (Maines et al., 1998) . Because of this bad adjust m ent, chronic stress may accelerate age-related damage, as it has been found in the hippocampus. A drenal glucocorticoids are thought to be respon sible for this damage, because of their ability to compromise energy metabolism and make neu rons m ore vulnerable to glutamate excitotoxicity. Stress has been found to decrease brain-derived neurotrophic factor (BDNF) mRNA in the hippo campus, whereas nerve growth factor (NGF) and neurotrophin-3 (NT-3) are increased, perhaps as a com pensatory mechanism to stress-induced-damage (Smith, 1996) .
